Cardiotoxicity from 5-Fluorouracil and its oral pro-drugs
Supervisors
Dorte Lisbeth Nielsen, Clinical Professor, MDSc, PhD
Kirsten Vistisen, Senior Consultant Oncologist, MD, PhD
Morten Schou, Senior Consultant Cardiologist, MD, PhD
Merete Vaage-Nilsen, Senior Consultant Cardiologist, MD, PhD
Morten Nielsen, MD Tumor-Infiltrating Lymphocytes (TILs) based Adoptive Cell Transfer immunotherapy (ACT) for patients with sarcomaSupervisors: Inge Marie Svane, Chief physician, Clinical Professor
Anders Krarup-Hansen, Chief physician, Associate professor , MD, PhD
Niels Junker, MD, PhD
Dan Taksony Solyom Høgdall
MicroRNA biomarkers in blood for early detection of cholangiocarcinoma and prediction of prognosis and treatment response.
Supervisors: Julia S. Johansen, Professor, MD, DMSc Ole Larsen, Senior Consultant, MD, PhD
Mogens K. Boisen, MD, PhD
Jesper Bøje Andersen, MSc, PhD, from Biotech Research and Innovation Centre (BRIC)
Magnus Pedersen, MD T cell therapy for patients with metastatic ovarian cancer
Supervisors: Per Thor Straten, Professor, Biologist
Mads Hald Andersen, Clinical Professor
Marco Donia, MD, PhD
Anne Prip, Nurse, Master of ArtsCommunication between
healthcare professionals and patients with cancer undergoing chemotherapy in an
outpatient clinicSupervisors: Mary Jarden, Senior Researcher, Universitetshospitalernes Center for Sundhedsfaglig Forskning (UCSF)
Dorte Lisbeth Nielsen, Clinical Professor, MDSc, PhD
Co-supervisor: Kathrine Hoffmann Pii, Anthropologist, Metropol
Arginase-1 Peptide Vaccine in Patients with Metastatic Solid Tumors
Supervisor: Inge Marie Svane
Anders Kverneland, MDAdoptive cell therapy across cancer diagnosesSupervisor: Inge Marie Svane, Chief physician, Clinical Professor
Co-supervisor: Marco Donia, MD, PhD
Personalized cancer immunotherapy using Neoepitope Peptide based Vaccines
Supervisor: Inge Marie Svane, Chief physician, Clinical Professor
Co-supervisor: Marco Donia, MD, PhD